Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis

医学 结直肠癌 内科学 炎症性肠病 肿瘤科 胃肠病学 总体生存率 癌症 存活率 结肠切除术 生存分析 梅德林 炎症性肠病 炎症反应
作者
Can Lu,Josefine Schardey,Tao Zhang,Alexander Crispin,Ulrich Wirth,Konrad W. Karcz,Alexandr V. Bazhin,Joachim Andrassy,Jens Werner,Florian Kühn
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:276 (5): e319-e330 被引量:72
标识
DOI:10.1097/sla.0000000000005339
摘要

OBJECTIVE: The aim of our study was to conduct a systematic review and meta-analysis comparing the survival outcomes of IBD-associated and non-IBD-associated CRC. SUMMARY OF BACKGROUND DATA: Investigations comparing the prognosis in CRC patients with and without IBD have yielded conflicting results. METHODS: PubMed/MEDLINE, Embase, Web of Science, Cochrane Library were searched for studies evaluating the prognostic outcomes between CRC patients with IBD and those without IBD. Estimates of survival-related outcomes and clinicopathological features in IBD-CRC and non-IBD CRC were pooled through random-effects or fix-effects models. The study is registered with PROSPERO, CRD42021261513. RESULTS: Of 12,768 records identified, twenty-five studies with 8034 IBD-CRC and 810,526 non-IBD CRC patients were included in the analysis. IBD-CRC patients have a significant worse overall survival (OS) with the hazard ratio (HR) of 1.33 [95% confidence interval (CI): 1.20-1.47] than those without IBD. Pooled estimates of cancer-specific survival demonstrated that IBD-CRC patients had a poorer cancer-specific survival than those without IBD with fixed-effect model (HR, 2.17; 95% CI: 1.68-2.78; P < 0.0001). Moreover, ulcerative colitis-associated CRC patients have favorable OS than Crohn's disease-associated CRC (HR 0.79,95% CI: 0.72-0.87). Compared to non-IBD-CRC, patients with IBD-associated CRC are characterized by an increased rate of poor differentiation (OR 2.02, 95% CI: 1.57-2.61), mucinous or signet ring cell carcinoma (OR 2.43, 95% CI: 1.34-4.42), synchronous tumors (OR 3.18, 95% CI: 2.26-4.47), right-sided CRC (OR 1.62, 95%CI: 1.05-2.05), male patients (OR 1.10, 95% CI: 1.05-1.16), and a reduced rate of R0 resections (OR 0.60, 95% CI: 0.44-0.82). CONCLUSIONS: IBD-CRC patients have a significant worse OS than patients with non-IBD CRC, which may be attributed to more aggressive histological characteristics and a lower rate of R0 resections at the primary tumor site. Optimized therapeutic standards and tailored follow-up strategies might improve the prognosis of IBD-CRC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Diane完成签到,获得积分10
刚刚
吴xl发布了新的文献求助10
1秒前
梦幻发布了新的文献求助10
1秒前
orixero的应助被Mr贱包子采纳,获得10
2秒前
fanf完成签到,获得积分10
2秒前
jj完成签到,获得积分10
2秒前
Sx13a发布了新的文献求助10
3秒前
夕犬水发布了新的文献求助10
3秒前
3秒前
4秒前
腼腆的乘云完成签到,获得积分10
4秒前
柴拆完成签到 ,获得积分10
5秒前
5秒前
DJY的应助被狗熊岭在逃翠花采纳,获得10
5秒前
111zzzzzz发布了新的文献求助10
6秒前
6秒前
6秒前
JhXia发布了新的文献求助10
7秒前
不会摸鱼的研究生不是好研究生完成签到,获得积分10
7秒前
福yyy发布了新的文献求助10
7秒前
7秒前
8秒前
dddd发布了新的文献求助10
9秒前
华仔的应助被梦M采纳,获得10
9秒前
chenxueneng完成签到,获得积分10
9秒前
molihuakai的应助被赛艇大师采纳,获得10
10秒前
情怀的应助被Eddie采纳,获得10
10秒前
wanci的应助被腼腆的乘云采纳,获得10
10秒前
兴奋石头发布了新的文献求助10
11秒前
梦幻完成签到,获得积分20
11秒前
11秒前
Jim完成签到,获得积分10
11秒前
Oxo完成签到,获得积分10
11秒前
科研通AI6.2的应助被aoao采纳,获得10
12秒前
水煮电吹风的应助被Jigsaw采纳,获得10
12秒前
典雅的夜安完成签到,获得积分10
12秒前
12秒前
云落发布了新的文献求助10
13秒前
op完成签到,获得积分10
14秒前
shadow_snow完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186541
求助须知:如何正确求助?哪些是违规求助? 9574894
关于积分的说明 21838647
捐赠科研通 7784174
什么是DOI,文献DOI怎么找? 3434800
关于科研通互助平台的介绍 2559183
邀请新用户注册赠送积分活动 2481565